Hongwen Li
- Oncology top 10%
- CAR-T cell therapy research 4
-
- Immune Cell Function and Interaction 8
-
- MicroRNA in disease regulation 4
- Animal Science and Zoology top 10%
-
- Asthma and respiratory diseases 7
-
- Viral Infectious Diseases and Gene Expression in Insects 4
- RNA modifications and cancer 4
-
- Virus-based gene therapy research 4
- Craniofacial Disorders and Treatments 4
- Co-authors
- Jianmin FangZhaoming LiWenting SongXuejing YaoQiaoyu XuDong LiMingzhi ZhangChangjiang Huang
- Cited by
- OncologyImmunologyCancer Research
- Journals
- BMC Pulmonary Medicine (3 papers)Frontiers in Immunology (2 papers)Cancer Letters (2 papers)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Hongwen Li
78 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 121
- Oncology 285
- Immunology 163
- Cancer Research 99
- Animal Science and Zoology 56
- Radiology, Nuclear Medicine and Imaging 127
Countries citing papers authored by Hongwen Li
This map shows the geographic impact of Hongwen Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongwen Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongwen Li more than expected).
Fields of papers citing papers by Hongwen Li
This network shows the impact of papers produced by Hongwen Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongwen Li. The network helps show where Hongwen Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hongwen Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 6 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 14 | |
| 5 | 2023 | 6 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 20 | |
| 10 | 2022 | 3 | |
| 11 | 2022 | 8 | |
| 12 | 2021 | 5 | |
| 13 | 2020 | 16 | |
| 14 | 2017 | 11 | |
| 15 | 2015 | 21 | |
| 16 | 2012 | 8 | |
| 17 | Clinical Research of Runzaozhiyang Capsule Combined with Loratadine to Treat 60 Patients with Chronic Urticaria | 2008 | 1 |
| 18 | Seroepidemiological survey on the infection of hepatitis E virus in deer and cattle in partial regions of China | 2006 | 1 |
| 19 | Study on quality development of naval orange (Citrus sinensis Osb.) during storage of fruit kept on tree. | 2005 | 1 |
| 20 | Study on the cell senescence, proliferation, and apoptosis in psoriatic lesions | 2003 | 1 |
About Hongwen Li
Hongwen Li is a scholar working on Cancer Research, Immunology, Immunology and Allergy, Oncology and Molecular Biology, having authored 83 papers that have together received 1.0k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (8 papers), Asthma and respiratory diseases (7 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers), RNA modifications and cancer (4 papers), Virus-based gene therapy research (4 papers), MicroRNA in disease regulation (4 papers), CAR-T cell therapy research (4 papers) and Craniofacial Disorders and Treatments (4 papers). The work is most often cited by research in Oncology (285 citations), Immunology (163 citations), Cancer Research (99 citations), Animal Science and Zoology (56 citations) and Radiology, Nuclear Medicine and Imaging (127 citations). Hongwen Li has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Jianmin Fang, Zhaoming Li, Wenting Song, Xuejing Yao, Qiaoyu Xu, Dong Li, Mingzhi Zhang, Changjiang Huang, Liguang Lou and Kun Xie. Their work appears in journals such as BMC Pulmonary Medicine, Frontiers in Immunology, Cancer Letters, Frontiers in Pharmacology and The Journal of Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.